WHERE THERAPIES GO VIRAL Trademark
Trademark Overview
On Thursday, September 25, 2025, a trademark application was filed for WHERE THERAPIES GO VIRAL with the United States Patent and Trademark Office. The USPTO has given the WHERE THERAPIES GO VIRAL trademark a serial number of 99413260. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, May 19, 2026. This trademark is owned by Vyriad, Inc.. The WHERE THERAPIES GO VIRAL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Medical and scientific research and development in the fields of cancer treatment and oncolytic virotherapy; Research and development of bio-pharmaceuticals for the treatment of cancer; Medical and scientific research in the fields of genetics and oncology; Research and development of technology in the fields of stem cells and stem cell therapy; Development of therapeutics and cell therapies; Scientific research and development of cell therapies, namely, chimeric antigen receptor T-cells (CAR-T) to cure solid tumor cancers and other cancers; Medical and scientific research services in the fields of genetics, cell therapy, oncology, immuno-oncology
General Information
| Serial Number | 99413260 |
| Word Mark | WHERE THERAPIES GO VIRAL |
| Filing Date | Thursday, September 25, 2025 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, May 19, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 19, 2026 |
Trademark Statements
| Goods and Services | Medical and scientific research and development in the fields of cancer treatment and oncolytic virotherapy; Research and development of bio-pharmaceuticals for the treatment of cancer; Medical and scientific research in the fields of genetics and oncology; Research and development of technology in the fields of stem cells and stem cell therapy; Development of therapeutics and cell therapies; Scientific research and development of cell therapies, namely, chimeric antigen receptor T-cells (CAR-T) to cure solid tumor cancers and other cancers; Medical and scientific research services in the fields of genetics, cell therapy, oncology, immuno-oncology |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 25, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, May 7, 2024 |
| First Use In Commerce Date | Tuesday, May 7, 2024 |
Trademark Owner History
| Party Name | Vyriad, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Rochester, MN 55901
US |
| Party Name | Vyriad, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Rochester, MN 55901
US |
Trademark Events
| Event Date | Event Description |
| Thursday, September 25, 2025 | NEW APPLICATION ENTERED |
| Thursday, September 25, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, September 25, 2025 | APPLICATION FILING RECEIPT MAILED |
| Monday, February 2, 2026 | ASSIGNED TO EXAMINER |
| Monday, February 2, 2026 | NON-FINAL ACTION WRITTEN |
| Monday, February 2, 2026 | NON-FINAL ACTION E-MAILED |
| Monday, February 2, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, April 7, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, April 7, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, April 7, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, April 24, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 13, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, May 13, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 19, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 19, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
